サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1130391

世界のトリプトレリン製剤市場：産業調査報告書、成長動向と競合分析 (2022年～2028年)

Global Triptorelin Drug Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
出版日: | 発行: QYResearch | ページ情報: 英文 104 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.97円
世界のトリプトレリン製剤市場：産業調査報告書、成長動向と競合分析 (2022年～2028年)
出版日: 2022年10月03日
発行: QYResearch
ページ情報: 英文 104 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、トリプトレリン製剤 (Triptorelin Drug) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 レポート概要

  • 調査対象範囲
  • 市場 タイプ別セグメント
    • 世界のトリプトレリン製剤の市場規模成長率：タイプ別 (2017 VS 2021 VS 2028)
    • 3.75 mg Vial
    • 11.25 mg Vial
    • 22.5 mg Vial
  • 市場 用途別セグメント
    • 世界のトリプトレリン製剤の市場シェア：アプリケーション別 (2017 VS 2021 VS 2028)
    • Advanced Prostate Cancer
    • Endometriosis
    • Uterine Fibroids
  • 調査目的
  • 対象期間

第2章 市場展望

  • 世界のトリプトレリン製剤 市場規模 (2017-2028)
    • 世界のトリプトレリン製剤の収益 (2017-2028)
    • 世界のトリプトレリン製剤の販売 (2017-2028)
  • 世界のトリプトレリン製剤 世界の主要地域における市場規模: 2017 VS 2021 VS 2028
    • 世界のトリプトレリン製剤の販売：地域別s (2017-2022)
    • 世界のトリプトレリン製剤の収益：地域別s (2017-2022)
  • 世界のトリプトレリン製剤 市場規模予測：地域別
    • 世界のトリプトレリン製剤の販売予測：地域別 (2023-2028)
    • 世界のトリプトレリン製剤の収益予測：地域別 (2023-2028)
  • 世界のトリプトレリン製剤 地域（国） ランキング別 市場規模
  • トリプトレリン製剤 市場動向
    • トリプトレリン製剤 市場トレンド
    • トリプトレリン製剤 市場の促進要因
    • トリプトレリン製剤 市場の課題
    • トリプトレリン製剤 市場の抑制要因

第3章 メーカー別の競争状況

  • 世界のトリプトレリン製剤の上位メーカー：販売別 (2017-2022)
    • 世界のトリプトレリン製剤の販売：メーカー別 (2017-2022)
    • 世界のトリプトレリン製剤の販売市場シェア：メーカー別 (2017-2022)
    • 世界の5大メーカーと10大メーカー by トリプトレリン製剤の販売 2021
  • 世界のメーカーのトリプトレリン製剤 収益別
    • 世界のトリプトレリン製剤の収益：メーカー別 (2017-2022)
    • トリプトレリン製剤 メーカー：収益別ランキング
    • 世界のトリプトレリン製剤の収益シェア：メーカー別 (2017-2022)
    • 世界のトリプトレリン製剤 市場集中度 (CR5 and HHI)
  • 世界のメーカーの企業タイプ別 (Tier 1, Tier 2 and Tier 3) & (売上高に基づいたトリプトレリン製剤 (2021年時点))
  • 世界のトリプトレリン製剤 メーカー別平均販売価格(ASP)
  • 主要なメーカーのトリプトレリン製剤 工場・事業所分布と供給地域
  • 主要メーカーの参入時期 トリプトレリン製剤 市場
  • 主要なメーカーのトリプトレリン製剤 取扱商品
  • M&A, 拡張計画

第4章 世界のトリプトレリン製剤 市場規模：タイプ別

  • 世界のトリプトレリン製剤の過去の市場概要：タイプ別 (2017-2022)
    • 世界のトリプトレリン製剤の販売市場シェア：タイプ別 (2017-2022)
    • 世界のトリプトレリン製剤の収益市場シェア：タイプ別 (2017-2022)
    • トリプトレリン製剤の価格：タイプ別 (2017-2022)
  • 世界のトリプトレリン製剤の市場 推定および予測：タイプ別 (2023-2028)
    • 世界のトリプトレリン製剤の販売予測：タイプ別 (2023-2028)
    • 世界のトリプトレリン製剤の収益予測：タイプ別 (2023-2028)
    • トリプトレリン製剤の価格予測：タイプ別 (2023-2028)

第5章 世界のトリプトレリン製剤 市場規模：アプリケーション別

  • 世界のトリプトレリン製剤の過去の市場概要：アプリケーション別 (2017-2022)
    • 世界のトリプトレリン製剤の販売市場シェア：アプリケーション別 (2017-2022)
    • 世界のトリプトレリン製剤の収益市場シェア：アプリケーション別 (2017-2022)
    • トリプトレリン製剤の価格：アプリケーション別 (2017-2022)
  • 世界のトリプトレリン製剤の市場 推定および予測：アプリケーション別 (2023-2028)
    • 世界のトリプトレリン製剤の販売予測：アプリケーション別 (2023-2028)
    • 世界のトリプトレリン製剤の収益予測：アプリケーション別 (2023-2028)
    • トリプトレリン製剤の価格予測：アプリケーション別 (2023-2028)

第6章 北米

  • 北米のトリプトレリン製剤の販売 企業別内訳
    • 北米のトリプトレリン製剤の販売 企業別 (2017-2022)
    • 北米のトリプトレリン製剤の収益 企業別 (2017-2022)
  • 北米のトリプトレリン製剤 市場規模：タイプ別
    • 北米のトリプトレリン製剤の販売：タイプ別 (2017-2028)
    • 北米のトリプトレリン製剤の収益：タイプ別 (2017-2028)
  • 北米のトリプトレリン製剤 市場規模：アプリケーション別
    • 北米のトリプトレリン製剤の販売：アプリケーション別 (2017-2028)
    • 北米のトリプトレリン製剤の収益：アプリケーション別 (2017-2028)
  • 北米のトリプトレリン製剤 市場規模：国別
    • 北米のトリプトレリン製剤の販売：国別 (2017-2028)
    • 北米のトリプトレリン製剤の収益：国別 (2017-2028)
    • 米国
    • カナダ

第7章 欧州

  • 欧州のトリプトレリン製剤の販売 企業別内訳
    • 欧州のトリプトレリン製剤の販売 企業別 (2017-2022)
    • 欧州のトリプトレリン製剤の収益 企業別 (2017-2022)
  • 欧州のトリプトレリン製剤 市場規模：タイプ別
    • 欧州のトリプトレリン製剤の販売：タイプ別 (2017-2028)
    • 欧州のトリプトレリン製剤の収益：タイプ別 (2017-2028)
  • 欧州のトリプトレリン製剤 市場規模：アプリケーション別
    • 欧州のトリプトレリン製剤の販売：アプリケーション別 (2017-2028)
    • 欧州のトリプトレリン製剤の収益：アプリケーション別 (2017-2028)
  • 欧州のトリプトレリン製剤 市場規模：国別
    • 欧州のトリプトレリン製剤の販売：国別 (2017-2028)
    • 欧州のトリプトレリン製剤の収益：国別 (2017-2028)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア

第8章 アジア太平洋

  • アジア太平洋のトリプトレリン製剤の販売 企業別内訳
    • アジア太平洋のトリプトレリン製剤の販売 企業別 (2017-2022)
    • アジア太平洋のトリプトレリン製剤の収益 企業別 (2017-2022)
  • アジア太平洋のトリプトレリン製剤 市場規模：タイプ別
    • アジア太平洋のトリプトレリン製剤の販売：タイプ別 (2017-2028)
    • アジア太平洋のトリプトレリン製剤の収益：タイプ別 (2017-2028)
  • アジア太平洋のトリプトレリン製剤 市場規模：アプリケーション別
    • アジア太平洋のトリプトレリン製剤の販売：アプリケーション別 (2017-2028)
    • アジア太平洋のトリプトレリン製剤の収益：アプリケーション別 (2017-2028)
  • アジア太平洋のトリプトレリン製剤 市場規模：地域別
    • アジア太平洋のトリプトレリン製剤の販売：地域別
    • アジア太平洋のトリプトレリン製剤の収益：地域別
    • 中国
    • 日本
    • 韓国
    • インド
    • オーストラリア
    • 台湾
    • インドネシア
    • タイ
    • マレーシア
    • フィリピン
    • ベトナム

第9章 ラテンアメリカ

  • ラテンアメリカのトリプトレリン製剤の販売 企業別内訳
    • ラテンアメリカのトリプトレリン製剤の販売 企業別 (2017-2022)
    • ラテンアメリカのトリプトレリン製剤の収益 企業別 (2017-2022)
  • ラテンアメリカのトリプトレリン製剤 市場規模：タイプ別
    • ラテンアメリカのトリプトレリン製剤の販売：タイプ別 (2017-2028)
    • ラテンアメリカのトリプトレリン製剤の収益：タイプ別 (2017-2028)
  • ラテンアメリカのトリプトレリン製剤 市場規模：アプリケーション別
    • ラテンアメリカのトリプトレリン製剤の販売：アプリケーション別 (2017-2028)
    • ラテンアメリカのトリプトレリン製剤の収益：アプリケーション別 (2017-2028)
  • ラテンアメリカのトリプトレリン製剤 市場規模：国別
    • ラテンアメリカのトリプトレリン製剤の販売：国別 (2017-2028)
    • ラテンアメリカのトリプトレリン製剤の収益：国別 (2017-2028)
    • メキシコ
    • ブラジル
    • アルゼンチン

第10章 中東・アフリカ

  • 中東・アフリカのトリプトレリン製剤の販売 企業別内訳
    • 中東・アフリカのトリプトレリン製剤の販売 企業別 (2017-2022)
    • 中東・アフリカのトリプトレリン製剤の収益 企業別 (2017-2022)
  • 中東・アフリカのトリプトレリン製剤 市場規模：タイプ別
    • 中東・アフリカのトリプトレリン製剤の販売：タイプ別 (2017-2028)
    • 中東・アフリカのトリプトレリン製剤の収益：タイプ別 (2017-2028)
  • 中東・アフリカのトリプトレリン製剤 市場規模：アプリケーション別
    • 中東・アフリカのトリプトレリン製剤の販売：アプリケーション別 (2017-2028)
    • 中東・アフリカのトリプトレリン製剤の収益：アプリケーション別 (2017-2028)
  • 中東・アフリカのトリプトレリン製剤 市場規模：国別
    • 中東・アフリカのトリプトレリン製剤の販売：国別 (2017-2028)
    • 中東・アフリカのトリプトレリン製剤の収益：国別 (2017-2028)
    • トルコ
    • サウジアラビア
    • UAE

第11章 企業プロファイル

  • Allergan
  • Debiopharm Group
  • Ipsen
  • Xbrane Biopharma
  • Chengdu Tiantaishan pharmaceutical
  • Arbor Pharmaceuticals
  • Ferring

第12章 バリューチェーンと販売チャネルの分析

  • トリプトレリン製剤 バリューチェーンの分析
  • トリプトレリン製剤 主要原材料分析
    • 主要原材料分析
    • 原材料の主要サプライヤー
  • トリプトレリン製剤 生産形態とプロセス
  • トリプトレリン製剤 販売およびマーケティング
    • トリプトレリン製剤 販売チャネル
    • トリプトレリン製剤 卸業者
  • トリプトレリン製剤 顧客

第13章 市場調査結果と結論

第14章 付録

図表

List of Tables

  • Table 1. Global Triptorelin Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
  • Table 2. Major Manufacturers of 3.75 mg Vial
  • Table 3. Major Manufacturers of 11.25 mg Vial
  • Table 4. Major Manufacturers of 22.5 mg Vial
  • Table 5. Global Triptorelin Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
  • Table 6. Global Triptorelin Drug Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
  • Table 7. Global Triptorelin Drug Sales by Region (2017-2022) & (K Units)
  • Table 8. Global Triptorelin Drug Sales Market Share by Region (2017-2022)
  • Table 9. Global Triptorelin Drug Revenue by Region (2017-2022) & (US$ Million)
  • Table 10. Global Triptorelin Drug Revenue Market Share by Region (2017-2022)
  • Table 11. Global Triptorelin Drug Sales Forecast by Region (2023-2028) & (K Units)
  • Table 12. Global Triptorelin Drug Sales Market Share Forecast by Region (2023-2028)
  • Table 13. Global Triptorelin Drug Revenue Forecast by Region (2023-2028) & (US$ Million)
  • Table 14. Global Triptorelin Drug Revenue Market Share Forecast by Region (2023-2028)
  • Table 15. Top Triptorelin Drug Regions (Countries) Ranking by Market Size (US$ Million) in 2021
  • Table 16. Triptorelin Drug Market Trends
  • Table 17. Triptorelin Drug Market Drivers
  • Table 18. Triptorelin Drug Market Challenges
  • Table 19. Triptorelin Drug Market Restraints
  • Table 20. Global Triptorelin Drug Sales by Manufacturers (2017-2022) & (K Units)
  • Table 21. Global Triptorelin Drug Sales Share by Manufacturers (2017-2022)
  • Table 22. Global Triptorelin Drug Revenue by Manufacturers (2017-2022) & (US$ Million)
  • Table 23. Ranking of Global Top Triptorelin Drug Manufacturers by Revenue (US$ Million) in 2021
  • Table 24. Triptorelin Drug Revenue Share by Manufacturers (2017-2022)
  • Table 25. Global Triptorelin Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 26. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Triptorelin Drug as of 2021)
  • Table 27. Key Manufacturers Triptorelin Drug Average Selling Price (ASP) & (2017-2022) & (USD/Unit)
  • Table 28. Key Manufacturers Triptorelin Drug Plants/Factories Distribution
  • Table 29. Key Manufacturers Triptorelin Drug Area Served
  • Table 30. Date of Key Manufacturers Enter into Triptorelin Drug Market
  • Table 31. Key Manufacturers Triptorelin Drug Product Type
  • Table 32. Mergers & Acquisitions, Expansion Plans
  • Table 33. Global Triptorelin Drug Sales (K Units) by Type (2017-2022)
  • Table 34. Global Triptorelin Drug Sales Share by Type (2017-2022)
  • Table 35. Global Triptorelin Drug Revenue (US$ Million) Market Share by Type (2017-2022)
  • Table 36. Global Triptorelin Drug Price (K Units) by Type (2017-2022)
  • Table 37. Global Triptorelin Drug Sales (K Units) by Type (2023-2028)
  • Table 38. Global Triptorelin Drug Sales Share by Type (2023-2028)
  • Table 39. Global Triptorelin Drug Revenue (US$ Million) Market Share by Type (2023-2028)
  • Table 40. Global Triptorelin Drug Revenue Share by Type (2023-2028)
  • Table 41. Global Triptorelin Drug Price (K Units) by Type (2023-2028)
  • Table 42. Global Triptorelin Drug Sales (K Units) by Application (2017-2022)
  • Table 43. Global Triptorelin Drug Sales Share by Application (2017-2022)
  • Table 44. Global Triptorelin Drug Revenue (US$ Million) Market Share by Application (2017-2022)
  • Table 45. Global Triptorelin Drug Price (K Units) by Application (2017-2022)
  • Table 46. Global Triptorelin Drug Sales (K Units) by Application (2023-2028)
  • Table 47. Global Triptorelin Drug Sales Share by Application (2023-2028)
  • Table 48. Global Triptorelin Drug Revenue (US$ Million) Market Share by Application (2023-2028)
  • Table 49. Global Triptorelin Drug Revenue Share by Application (2023-2028)
  • Table 50. Global Triptorelin Drug Price (K Units) by Application (2023-2028)
  • Table 51. North America Triptorelin Drug Sales by Company (2017-2022) & (K Units)
  • Table 52. North America Triptorelin Drug Sales Market Share by Company (2017-2022)
  • Table 53. North America Triptorelin Drug Revenue by Company (2017-2022) & (US$ Million)
  • Table 54. North America Triptorelin Drug Revenue Market Share by Company (2017-2022)
  • Table 55. North America Triptorelin Drug Sales by Type (2017-2022) & (K Units)
  • Table 56. North America Triptorelin Drug Sales by Type (2023-2028) & (K Units)
  • Table 57. North America Triptorelin Drug Revenue by Type (2017-2022) & (US$ Million)
  • Table 58. North America Triptorelin Drug Revenue by Type (2023-2028) & (US$ Million)
  • Table 59. North America Triptorelin Drug Sales by Application (2017-2022) & (K Units)
  • Table 60. North America Triptorelin Drug Sales by Application (2023-2028) & (K Units)
  • Table 61. North America Triptorelin Drug Revenue by Application (2017-2022) & (US$ Million)
  • Table 62. North America Triptorelin Drug Revenue by Application (2023-2028) & (US$ Million)
  • Table 63. North America Triptorelin Drug Sales by Country (2017-2022) & (K Units)
  • Table 64. North America Triptorelin Drug Sales by Country (2023-2028) & (K Units)
  • Table 65. North America Triptorelin Drug Revenue by Country (2017-2022) & (US$ Million)
  • Table 66. North America Triptorelin Drug Revenue by Country (2023-2028) & (US$ Million)
  • Table 67. Europe Triptorelin Drug Sales by Company (2017-2022) & (K Units)
  • Table 68. Europe Triptorelin Drug Sales Market Share by Company (2017-2022)
  • Table 69. Europe Triptorelin Drug Revenue by Company (2017-2022) & (US$ Million)
  • Table 70. Europe Triptorelin Drug Revenue Market Share by Company (2017-2022)
  • Table 71. Europe Triptorelin Drug Sales by Type (2017-2022) & (K Units)
  • Table 72. Europe Triptorelin Drug Sales by Type (2023-2028) & (K Units)
  • Table 73. Europe Triptorelin Drug Revenue by Type (2017-2022) & (US$ Million)
  • Table 74. Europe Triptorelin Drug Revenue by Type (2023-2028) & (US$ Million)
  • Table 75. Europe Triptorelin Drug Sales by Application (2017-2022) & (K Units)
  • Table 76. Europe Triptorelin Drug Sales by Application (2023-2028) & (K Units)
  • Table 77. Europe Triptorelin Drug Revenue by Application (2017-2022) & (US$ Million)
  • Table 78. Europe Triptorelin Drug Revenue by Application (2023-2028) & (US$ Million)
  • Table 79. Europe Triptorelin Drug Sales by Country (2017-2022) & (K Units)
  • Table 80. Europe Triptorelin Drug Sales by Country (2023-2028) & (K Units)
  • Table 81. Europe Triptorelin Drug Revenue by Country (2017-2022) & (US$ Million)
  • Table 82. Europe Triptorelin Drug Revenue by Country (2023-2028) & (US$ Million)
  • Table 83. Asia Pacific Triptorelin Drug Sales by Company (2017-2022) & (K Units)
  • Table 84. Asia Pacific Triptorelin Drug Sales Market Share by Company (2017-2022)
  • Table 85. Asia Pacific Triptorelin Drug Revenue by Company (2017-2022) & (US$ Million)
  • Table 86. Asia Pacific Triptorelin Drug Revenue Market Share by Company (2017-2022)
  • Table 87. Asia Pacific Triptorelin Drug Sales by Type (2017-2022) & (K Units)
  • Table 88. Asia Pacific Triptorelin Drug Sales by Type (2023-2028) & (K Units)
  • Table 89. Asia Pacific Triptorelin Drug Revenue by Type (2017-2022) & (US$ Million)
  • Table 90. Asia Pacific Triptorelin Drug Revenue by Type (2023-2028) & (US$ Million)
  • Table 91. Asia Pacific Triptorelin Drug Sales by Application (2017-2022) & (K Units)
  • Table 92. Asia Pacific Triptorelin Drug Sales by Application (2023-2028) & (K Units)
  • Table 93. Asia Pacific Triptorelin Drug Revenue by Application (2017-2022) & (US$ Million)
  • Table 94. Asia Pacific Triptorelin Drug Revenue by Application (2023-2028) & (US$ Million)
  • Table 95. Asia Pacific Triptorelin Drug Sales by Region (2017-2022) & (K Units)
  • Table 96. Asia Pacific Triptorelin Drug Sales by Region (2023-2028) & (K Units)
  • Table 97. Asia Pacific Triptorelin Drug Revenue by Region (2017-2022) & (US$ Million)
  • Table 98. Asia Pacific Triptorelin Drug Revenue by Region (2023-2028) & (US$ Million)
  • Table 99. Latin America Triptorelin Drug Sales by Company (2017-2022) & (K Units)
  • Table 100. Latin America Triptorelin Drug Sales Market Share by Company (2017-2022)
  • Table 101. Latin America Triptorelin Drug Revenue by Company (2017-2022) & (US$ Million)
  • Table 102. Latin America Triptorelin Drug Revenue Market Share by Company (2017-2022)
  • Table 103. Latin America Triptorelin Drug Sales by Type (2017-2022) & (K Units)
  • Table 104. Latin America Triptorelin Drug Sales by Type (2023-2028) & (K Units)
  • Table 105. Latin America Triptorelin Drug Revenue by Type (2017-2022) & (US$ Million)
  • Table 106. Latin America Triptorelin Drug Revenue by Type (2023-2028) & (US$ Million)
  • Table 107. Latin America Triptorelin Drug Sales by Application (2017-2022) & (K Units)
  • Table 108. Latin America Triptorelin Drug Sales by Application (2023-2028) & (K Units)
  • Table 109. Latin America Triptorelin Drug Revenue by Application (2017-2022) & (US$ Million)
  • Table 110. Latin America Triptorelin Drug Revenue by Application (2023-2028) & (US$ Million)
  • Table 111. Latin America Triptorelin Drug Sales by Country (2017-2022) & (K Units)
  • Table 112. Latin America Triptorelin Drug Sales by Country (2023-2028) & (K Units)
  • Table 113. Latin America Triptorelin Drug Revenue by Country (2017-2022) & (US$ Million)
  • Table 114. Latin America Triptorelin Drug Revenue by Country (2023-2028) & (US$ Million)
  • Table 115. Middle East and Africa Triptorelin Drug Sales by Company (2017-2022) & (K Units)
  • Table 116. Middle East and Africa Triptorelin Drug Sales Market Share by Company (2017-2022)
  • Table 117. Middle East and Africa Triptorelin Drug Revenue by Company (2017-2022) & (US$ Million)
  • Table 118. Middle East and Africa Triptorelin Drug Revenue Market Share by Company (2017-2022)
  • Table 119. Middle East and Africa Triptorelin Drug Sales by Type (2017-2022) & (K Units)
  • Table 120. Middle East and Africa Triptorelin Drug Sales by Type (2023-2028) & (K Units)
  • Table 121. Middle East and Africa Triptorelin Drug Revenue by Type (2017-2022) & (US$ Million)
  • Table 122. Middle East and Africa Triptorelin Drug Revenue by Type (2023-2028) & (US$ Million)
  • Table 123. Middle East and Africa Triptorelin Drug Sales by Application (2017-2022) & (K Units)
  • Table 124. Middle East and Africa Triptorelin Drug Sales by Application (2023-2028) & (K Units)
  • Table 125. Middle East and Africa Triptorelin Drug Revenue by Application (2017-2022) & (US$ Million)
  • Table 126. Middle East and Africa Triptorelin Drug Revenue by Application (2023-2028) & (US$ Million)
  • Table 127. Middle East and Africa Triptorelin Drug Sales by Country (2017-2022) & (K Units)
  • Table 128. Middle East and Africa Triptorelin Drug Sales by Country (2023-2028) & (K Units)
  • Table 129. Middle East and Africa Triptorelin Drug Revenue by Country (2017-2022) & (US$ Million)
  • Table 130. Middle East and Africa Triptorelin Drug Revenue by Country (2023-2028) & (US$ Million)
  • Table 131. Allergan Corporation Information
  • Table 132. Allergan Description and Overview
  • Table 133. Allergan Triptorelin Drug Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
  • Table 134. Allergan Triptorelin Drug Product and Services
  • Table 135. Allergan Triptorelin Drug SWOT Analysis
  • Table 136. Allergan Recent Developments
  • Table 137. Debiopharm Group Corporation Information
  • Table 138. Debiopharm Group Description and Overview
  • Table 139. Debiopharm Group Triptorelin Drug Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
  • Table 140. Debiopharm Group Triptorelin Drug Product and Services
  • Table 141. Debiopharm Group Triptorelin Drug SWOT Analysis
  • Table 142. Debiopharm Group Recent Developments
  • Table 143. Ipsen Corporation Information
  • Table 144. Ipsen Description and Overview
  • Table 145. Ipsen Triptorelin Drug Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
  • Table 146. Ipsen Triptorelin Drug Product and Services
  • Table 147. Ipsen Triptorelin Drug SWOT Analysis
  • Table 148. Ipsen Recent Developments
  • Table 149. Xbrane Biopharma Corporation Information
  • Table 150. Xbrane Biopharma Description and Overview
  • Table 151. Xbrane Biopharma Triptorelin Drug Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
  • Table 152. Xbrane Biopharma Triptorelin Drug Product and Services
  • Table 153. Xbrane Biopharma Triptorelin Drug SWOT Analysis
  • Table 154. Xbrane Biopharma Recent Developments
  • Table 155. Chengdu Tiantaishan pharmaceutical Corporation Information
  • Table 156. Chengdu Tiantaishan pharmaceutical Description and Overview
  • Table 157. Chengdu Tiantaishan pharmaceutical Triptorelin Drug Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
  • Table 158. Chengdu Tiantaishan pharmaceutical Triptorelin Drug Product and Services
  • Table 159. Chengdu Tiantaishan pharmaceutical Triptorelin Drug SWOT Analysis
  • Table 160. Chengdu Tiantaishan pharmaceutical Recent Developments
  • Table 161. Arbor Pharmaceuticals Corporation Information
  • Table 162. Arbor Pharmaceuticals Description and Overview
  • Table 163. Arbor Pharmaceuticals Triptorelin Drug Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
  • Table 164. Arbor Pharmaceuticals Triptorelin Drug Product and Services
  • Table 165. Arbor Pharmaceuticals Triptorelin Drug SWOT Analysis
  • Table 166. Arbor Pharmaceuticals Recent Developments
  • Table 167. Ferring Corporation Information
  • Table 168. Ferring Description and Overview
  • Table 169. Ferring Triptorelin Drug Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
  • Table 170. Ferring Triptorelin Drug Product and Services
  • Table 171. Ferring Triptorelin Drug SWOT Analysis
  • Table 172. Ferring Recent Developments
  • Table 173. Key Raw Materials Lists
  • Table 174. Raw Materials Key Suppliers Lists
  • Table 175. Triptorelin Drug Distributors List
  • Table 176. Triptorelin Drug Customers List
  • Table 177. Research Programs/Design for This Report
  • Table 178. Key Data Information from Secondary Sources
  • Table 179. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Triptorelin Drug Product Picture
  • Figure 2. Global Triptorelin Drug Sales Market Share by Type in 2021 & 2028
  • Figure 3. 3.75 mg Vial Product Picture
  • Figure 4. 11.25 mg Vial Product Picture
  • Figure 5. 22.5 mg Vial Product Picture
  • Figure 6. Global Triptorelin Drug Sales Market Share by Application in 2021 & 2028
  • Figure 7. Advanced Prostate Cancer Use Case
  • Figure 8. Endometriosis Use Case
  • Figure 9. Uterine Fibroids Use Case
  • Figure 10. Triptorelin Drug Report Years Considered
  • Figure 11. Global Triptorelin Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 12. Global Triptorelin Drug Market Size 2017-2028 (US$ Million)
  • Figure 13. Global Triptorelin Drug Sales (2017-2022) & (K Units)
  • Figure 14. Global Triptorelin Drug Market Size Market Share by Region: 2021 VS 2028
  • Figure 15. Global Triptorelin Drug Sales Market Share by Region (2017-2022)
  • Figure 16. Global Triptorelin Drug Sales Market Share by Region in 2021
  • Figure 17. Global Triptorelin Drug Revenue Market Share by Region in 2017 VS 2021
  • Figure 18. Global Triptorelin Drug Sales Share by Manufacturers in 2021
  • Figure 19. The 5 and 10 Largest Manufacturers in the World: Market Share by Triptorelin Drug Sales in 2021
  • Figure 20. Triptorelin Drug Revenue Share by Manufacturers in 2021
  • Figure 21. Triptorelin Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
  • Figure 22. Global Triptorelin Drug Revenue Share by Type (2017-2022)
  • Figure 23. Global Triptorelin Drug Revenue Growth Rate by Type in 2017 & 2021
  • Figure 24. Global Triptorelin Drug Revenue Share by Application (2017-2022)
  • Figure 25. Global Triptorelin Drug Revenue Growth Rate by Application in 2017 & 2021
  • Figure 26. North America Triptorelin Drug Sales Market Share by Type (2017-2028)
  • Figure 27. North America Triptorelin Drug Revenue Market Share by Type (2017-2028)
  • Figure 28. North America Triptorelin Drug Sales Market Share by Application (2017-2028)
  • Figure 29. North America Triptorelin Drug Revenue Market Share by Application (2017-2028)
  • Figure 30. North America Triptorelin Drug Sales Share by Country (2017-2028)
  • Figure 31. North America Triptorelin Drug Revenue Share by Country (2017-2028)
  • Figure 32. U.S. Triptorelin Drug Revenue (2017-2028) & (US$ Million)
  • Figure 33. Canada Triptorelin Drug Revenue (2017-2028) & (US$ Million)
  • Figure 34. Europe Triptorelin Drug Sales Market Share by Type (2017-2028)
  • Figure 35. Europe Triptorelin Drug Revenue Market Share by Type (2017-2028)
  • Figure 36. Europe Triptorelin Drug Sales Market Share by Application (2017-2028)
  • Figure 37. Europe Triptorelin Drug Revenue Market Share by Application (2017-2028)
  • Figure 38. Europe Triptorelin Drug Sales Share by Country (2017-2028)
  • Figure 39. Europe Triptorelin Drug Revenue Share by Country (2017-2028)
  • Figure 40. Germany Triptorelin Drug Revenue (2017-2028) & (US$ Million)
  • Figure 41. France Triptorelin Drug Revenue (2017-2028) & (US$ Million)
  • Figure 42. U.K. Triptorelin Drug Revenue (2017-2028) & (US$ Million)
  • Figure 43. Italy Triptorelin Drug Revenue (2017-2028) & (US$ Million)
  • Figure 44. Russia Triptorelin Drug Revenue (2017-2028) & (US$ Million)
  • Figure 45. Asia Pacific Triptorelin Drug Sales Market Share by Type (2017-2028)
  • Figure 46. Asia Pacific Triptorelin Drug Revenue Market Share by Type (2017-2028)
  • Figure 47. Asia Pacific Triptorelin Drug Sales Market Share by Application (2017-2028)
  • Figure 48. Asia Pacific Triptorelin Drug Revenue Market Share by Application (2017-2028)
  • Figure 49. Asia Pacific Triptorelin Drug Sales Share by Region (2017-2028)
  • Figure 50. Asia Pacific Triptorelin Drug Revenue Share by Region (2017-2028)
  • Figure 51. China Triptorelin Drug Revenue (2017-2028) & (US$ Million)
  • Figure 52. Japan Triptorelin Drug Revenue (2017-2028) & (US$ Million)
  • Figure 53. South Korea Triptorelin Drug Revenue (2017-2028) & (US$ Million)
  • Figure 54. India Triptorelin Drug Revenue (2017-2028) & (US$ Million)
  • Figure 55. Australia Triptorelin Drug Revenue (2017-2028) & (US$ Million)
  • Figure 56. Taiwan Triptorelin Drug Revenue (2017-2028) & (US$ Million)
  • Figure 57. Indonesia Triptorelin Drug Revenue (2017-2028) & (US$ Million)
  • Figure 58. Thailand Triptorelin Drug Revenue (2017-2028) & (US$ Million)
  • Figure 59. Malaysia Triptorelin Drug Revenue (2017-2028) & (US$ Million)
  • Figure 60. Philippines Triptorelin Drug Revenue (2017-2028) & (US$ Million)
  • Figure 61. Vietnam Triptorelin Drug Revenue (2017-2028) & (US$ Million)
  • Figure 62. Latin America Triptorelin Drug Sales Market Share by Type (2017-2028)
  • Figure 63. Latin America Triptorelin Drug Revenue Market Share by Type (2017-2028)
  • Figure 64. Latin America Triptorelin Drug Sales Market Share by Application (2017-2028)
  • Figure 65. Latin America Triptorelin Drug Revenue Market Share by Application (2017-2028)
  • Figure 66. Latin America Triptorelin Drug Sales Share by Country (2017-2028)
  • Figure 67. Latin America Triptorelin Drug Revenue Share by Country (2017-2028)
  • Figure 68. Mexico Triptorelin Drug Revenue (2017-2028) & (US$ Million)
  • Figure 69. Brazil Triptorelin Drug Revenue (2017-2028) & (US$ Million)
  • Figure 70. Argentina Triptorelin Drug Revenue (2017-2028) & (US$ Million)
  • Figure 71. Middle East and Africa Triptorelin Drug Sales Market Share by Type (2017-2028)
  • Figure 72. Middle East and Africa Triptorelin Drug Revenue Market Share by Type (2017-2028)
  • Figure 73. Middle East and Africa Triptorelin Drug Sales Market Share by Application (2017-2028)
  • Figure 74. Middle East and Africa Triptorelin Drug Revenue Market Share by Application (2017-2028)
  • Figure 75. Middle East and Africa Triptorelin Drug Sales Share by Country (2017-2028)
  • Figure 76. Middle East and Africa Triptorelin Drug Revenue Share by Country (2017-2028)
  • Figure 77. Turkey Triptorelin Drug Revenue (2017-2028) & (US$ Million)
  • Figure 78. Saudi Arabia Triptorelin Drug Revenue (2017-2028) & (US$ Million)
  • Figure 79. UAE Triptorelin Drug Revenue (2017-2028) & (US$ Million)
  • Figure 80. Triptorelin Drug Value Chain
  • Figure 81. Triptorelin Drug Production Process
  • Figure 82. Channels of Distribution
  • Figure 83. Distributors Profiles
  • Figure 84. Bottom-up and Top-down Approaches for This Report
  • Figure 85. Data Triangulation
  • Figure 86. Key Executives Interviewed
目次

This research report focuses on the Triptorelin Drug Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Overview

  • 1.1 Research Scope
  • 1.2 Market Segment by Type
    • 1.2.1 Global Triptorelin Drug Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
    • 1.2.2 3.75 mg Vial
    • 1.2.3 11.25 mg Vial
    • 1.2.4 22.5 mg Vial
  • 1.3 Market Segment by Application
    • 1.3.1 Global Triptorelin Drug Market Share by Application (2017 VS 2021 VS 2028)
    • 1.3.2 Advanced Prostate Cancer
    • 1.3.3 Endometriosis
    • 1.3.4 Uterine Fibroids
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Market Perspective

  • 2.1 Global Triptorelin Drug Market Size (2017-2028)
    • 2.1.1 Global Triptorelin Drug Revenue (2017-2028)
    • 2.1.2 Global Triptorelin Drug Sales (2017-2028)
  • 2.2 Global Triptorelin Drug Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
    • 2.2.1 Global Triptorelin Drug Sales by Regions (2017-2022)
    • 2.2.2 Global Triptorelin Drug Revenue by Regions (2017-2022)
  • 2.3 Global Triptorelin Drug Market Size Forecast by Region
    • 2.3.1 Global Triptorelin Drug Sales Forecast by Region (2023-2028)
    • 2.3.2 Global Triptorelin Drug Revenue Forecast by Region (2023-2028)
  • 2.4 Global Top Triptorelin Drug Regions (Countries) Ranking by Market Size
  • 2.5 Triptorelin Drug Market Dynamics
    • 2.5.1 Triptorelin Drug Market Trends
    • 2.5.2 Triptorelin Drug Market Drivers
    • 2.5.3 Triptorelin Drug Market Challenges
    • 2.5.4 Triptorelin Drug Market Restraints

3 Competitive Landscape by Manufacturers

  • 3.1 Global Top Triptorelin Drug Manufacturers by Sales (2017-2022)
    • 3.1.1 Global Triptorelin Drug Sales by Manufacturers (2017-2022)
    • 3.1.2 Global Triptorelin Drug Sales Market Share by Manufacturers (2017-2022)
    • 3.1.3 Global 5 and 10 Largest Manufacturers by Triptorelin Drug Sales in 2021
  • 3.2 Global Top Manufacturers Triptorelin Drug by Revenue
    • 3.2.1 Global Triptorelin Drug Revenue by Manufacturers (2017-2022)
    • 3.2.2 Top Triptorelin Drug Manufacturers Covered: Ranking by Revenue
    • 3.2.3 Global Triptorelin Drug Revenue Share by Manufacturers (2017-2022)
    • 3.2.4 Global Triptorelin Drug Market Concentration Ratio (CR5 and HHI)
  • 3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Triptorelin Drug as of 2021)
  • 3.4 Global Triptorelin Drug Average Selling Price (ASP) by Manufacturers
  • 3.5 Key Manufacturers Triptorelin Drug Plants/Factories Distribution and Area Served
  • 3.6 Date of Key Manufacturers Enter into Triptorelin Drug Market
  • 3.7 Key Manufacturers Triptorelin Drug Product Offered
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Global Triptorelin Drug Market Size by Type

  • 4.1 Global Triptorelin Drug Historic Market Review by Type (2017-2022)
    • 4.1.1 Global Triptorelin Drug Sales Market Share by Type (2017-2022)
    • 4.1.2 Global Triptorelin Drug Revenue Market Share by Type (2017-2022)
    • 4.1.3 Triptorelin Drug Price by Type (2017-2022)
  • 4.2 Global Triptorelin Drug Market Estimates and Forecasts by Type (2023-2028)
    • 4.2.1 Global Triptorelin Drug Sales Forecast by Type (2023-2028)
    • 4.2.2 Global Triptorelin Drug Revenue Forecast by Type (2023-2028)
    • 4.2.3 Triptorelin Drug Price Forecast by Type (2023-2028)

5 Global Triptorelin Drug Market Size by Application

  • 5.1 Global Triptorelin Drug Historic Market Review by Application (2017-2022)
    • 5.1.1 Global Triptorelin Drug Sales Market Share by Application (2017-2022)
    • 5.1.2 Global Triptorelin Drug Revenue Market Share by Application (2017-2022)
    • 5.1.3 Triptorelin Drug Price by Application (2017-2022)
  • 5.2 Global Triptorelin Drug Market Estimates and Forecasts by Application (2023-2028)
    • 5.2.1 Global Triptorelin Drug Sales Forecast by Application (2023-2028)
    • 5.2.2 Global Triptorelin Drug Revenue Forecast by Application (2023-2028)
    • 5.2.3 Triptorelin Drug Price Forecast by Application (2023-2028)

6 North America

  • 6.1 North America Triptorelin Drug Sales Breakdown by Company
    • 6.1.1 North America Triptorelin Drug Sales by Company (2017-2022)
    • 6.1.2 North America Triptorelin Drug Revenue by Company (2017-2022)
  • 6.2 North America Triptorelin Drug Market Size by Type
    • 6.2.1 North America Triptorelin Drug Sales by Type (2017-2028)
    • 6.2.2 North America Triptorelin Drug Revenue by Type (2017-2028)
  • 6.3 North America Triptorelin Drug Market Size by Application
    • 6.3.1 North America Triptorelin Drug Sales by Application (2017-2028)
    • 6.3.2 North America Triptorelin Drug Revenue by Application (2017-2028)
  • 6.4 North America Triptorelin Drug Market Size by Country
    • 6.4.1 North America Triptorelin Drug Sales by Country (2017-2028)
    • 6.4.2 North America Triptorelin Drug Revenue by Country (2017-2028)
    • 6.4.3 U.S.
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Triptorelin Drug Sales Breakdown by Company
    • 7.1.1 Europe Triptorelin Drug Sales by Company (2017-2022)
    • 7.1.2 Europe Triptorelin Drug Revenue by Company (2017-2022)
  • 7.2 Europe Triptorelin Drug Market Size by Type
    • 7.2.1 Europe Triptorelin Drug Sales by Type (2017-2028)
    • 7.2.2 Europe Triptorelin Drug Revenue by Type (2017-2028)
  • 7.3 Europe Triptorelin Drug Market Size by Application
    • 7.3.1 Europe Triptorelin Drug Sales by Application (2017-2028)
    • 7.3.2 Europe Triptorelin Drug Revenue by Application (2017-2028)
  • 7.4 Europe Triptorelin Drug Market Size by Country
    • 7.4.1 Europe Triptorelin Drug Sales by Country (2017-2028)
    • 7.4.2 Europe Triptorelin Drug Revenue by Country (2017-2028)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia

8 Asia Pacific

  • 8.1 Asia Pacific Triptorelin Drug Sales Breakdown by Company
    • 8.1.1 Asia Pacific Triptorelin Drug Sales by Company (2017-2022)
    • 8.1.2 Asia Pacific Triptorelin Drug Revenue by Company (2017-2022)
  • 8.2 Asia Pacific Triptorelin Drug Market Size by Type
    • 8.2.1 Asia Pacific Triptorelin Drug Sales by Type (2017-2028)
    • 8.2.2 Asia Pacific Triptorelin Drug Revenue by Type (2017-2028)
  • 8.3 Asia Pacific Triptorelin Drug Market Size by Application
    • 8.3.1 Asia Pacific Triptorelin Drug Sales by Application (2017-2028)
    • 8.3.2 Asia Pacific Triptorelin Drug Revenue by Application (2017-2028)
  • 8.4 Asia Pacific Triptorelin Drug Market Size by Region
    • 8.4.1 Asia Pacific Triptorelin Drug Sales by Region
    • 8.4.2 Asia Pacific Triptorelin Drug Revenue by Region
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 India
    • 8.4.7 Australia
    • 8.4.8 Taiwan
    • 8.4.9 Indonesia
    • 8.4.10 Thailand
    • 8.4.11 Malaysia
    • 8.4.12 Philippines
    • 8.4.13 Vietnam

9 Latin America

  • 9.1 Latin America Triptorelin Drug Sales Breakdown by Company
    • 9.1.1 Latin America Triptorelin Drug Sales by Company (2017-2022)
    • 9.1.2 Latin America Triptorelin Drug Revenue by Company (2017-2022)
  • 9.2 Latin America Triptorelin Drug Market Size by Type
    • 9.2.1 Latin America Triptorelin Drug Sales by Type (2017-2028)
    • 9.2.2 Latin America Triptorelin Drug Revenue by Type (2017-2028)
  • 9.3 Latin America Triptorelin Drug Market Size by Application
    • 9.3.1 Latin America Triptorelin Drug Sales by Application (2017-2028)
    • 9.3.2 Latin America Triptorelin Drug Revenue by Application (2017-2028)
  • 9.4 Latin America Triptorelin Drug Market Size by Country
    • 9.4.1 Latin America Triptorelin Drug Sales by Country (2017-2028)
    • 9.4.2 Latin America Triptorelin Drug Revenue by Country (2017-2028)
    • 9.4.3 Mexico
    • 9.4.4 Brazil
    • 9.4.5 Argentina

10 Middle East and Africa

  • 10.1 Middle East and Africa Triptorelin Drug Sales Breakdown by Company
    • 10.1.1 Middle East and Africa Triptorelin Drug Sales by Company (2017-2022)
    • 10.1.2 Middle East and Africa Triptorelin Drug Revenue by Company (2017-2022)
  • 10.2 Middle East and Africa Triptorelin Drug Market Size by Type
    • 10.2.1 Middle East and Africa Triptorelin Drug Sales by Type (2017-2028)
    • 10.2.2 Middle East and Africa Triptorelin Drug Revenue by Type (2017-2028)
  • 10.3 Middle East and Africa Triptorelin Drug Market Size by Application
    • 10.3.1 Middle East and Africa Triptorelin Drug Sales by Application (2017-2028)
    • 10.3.2 Middle East and Africa Triptorelin Drug Revenue by Application (2017-2028)
  • 10.4 Middle East and Africa Triptorelin Drug Market Size by Country
    • 10.4.1 Middle East and Africa Triptorelin Drug Sales by Country (2017-2028)
    • 10.4.2 Middle East and Africa Triptorelin Drug Revenue by Country (2017-2028)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Company Profiles

  • 11.1 Allergan
    • 11.1.1 Allergan Corporation Information
    • 11.1.2 Allergan Overview
    • 11.1.3 Allergan Triptorelin Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
    • 11.1.4 Allergan Triptorelin Drug Products and Services
    • 11.1.5 Allergan Triptorelin Drug SWOT Analysis
    • 11.1.6 Allergan Recent Developments
  • 11.2 Debiopharm Group
    • 11.2.1 Debiopharm Group Corporation Information
    • 11.2.2 Debiopharm Group Overview
    • 11.2.3 Debiopharm Group Triptorelin Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
    • 11.2.4 Debiopharm Group Triptorelin Drug Products and Services
    • 11.2.5 Debiopharm Group Triptorelin Drug SWOT Analysis
    • 11.2.6 Debiopharm Group Recent Developments
  • 11.3 Ipsen
    • 11.3.1 Ipsen Corporation Information
    • 11.3.2 Ipsen Overview
    • 11.3.3 Ipsen Triptorelin Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
    • 11.3.4 Ipsen Triptorelin Drug Products and Services
    • 11.3.5 Ipsen Triptorelin Drug SWOT Analysis
    • 11.3.6 Ipsen Recent Developments
  • 11.4 Xbrane Biopharma
    • 11.4.1 Xbrane Biopharma Corporation Information
    • 11.4.2 Xbrane Biopharma Overview
    • 11.4.3 Xbrane Biopharma Triptorelin Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
    • 11.4.4 Xbrane Biopharma Triptorelin Drug Products and Services
    • 11.4.5 Xbrane Biopharma Triptorelin Drug SWOT Analysis
    • 11.4.6 Xbrane Biopharma Recent Developments
  • 11.5 Chengdu Tiantaishan pharmaceutical
    • 11.5.1 Chengdu Tiantaishan pharmaceutical Corporation Information
    • 11.5.2 Chengdu Tiantaishan pharmaceutical Overview
    • 11.5.3 Chengdu Tiantaishan pharmaceutical Triptorelin Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
    • 11.5.4 Chengdu Tiantaishan pharmaceutical Triptorelin Drug Products and Services
    • 11.5.5 Chengdu Tiantaishan pharmaceutical Triptorelin Drug SWOT Analysis
    • 11.5.6 Chengdu Tiantaishan pharmaceutical Recent Developments
  • 11.6 Arbor Pharmaceuticals
    • 11.6.1 Arbor Pharmaceuticals Corporation Information
    • 11.6.2 Arbor Pharmaceuticals Overview
    • 11.6.3 Arbor Pharmaceuticals Triptorelin Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
    • 11.6.4 Arbor Pharmaceuticals Triptorelin Drug Products and Services
    • 11.6.5 Arbor Pharmaceuticals Triptorelin Drug SWOT Analysis
    • 11.6.6 Arbor Pharmaceuticals Recent Developments
  • 11.7 Ferring
    • 11.7.1 Ferring Corporation Information
    • 11.7.2 Ferring Overview
    • 11.7.3 Ferring Triptorelin Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
    • 11.7.4 Ferring Triptorelin Drug Products and Services
    • 11.7.5 Ferring Triptorelin Drug SWOT Analysis
    • 11.7.6 Ferring Recent Developments

12 Value Chain and Sales Channels Analysis

  • 12.1 Triptorelin Drug Value Chain Analysis
  • 12.2 Triptorelin Drug Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 Triptorelin Drug Production Mode & Process
  • 12.4 Triptorelin Drug Sales and Marketing
    • 12.4.1 Triptorelin Drug Sales Channels
    • 12.4.2 Triptorelin Drug Distributors
  • 12.5 Triptorelin Drug Customers

13 Research Findings and Conclusion

14 Appendix

  • 14.1 Research Methodology
    • 14.1.1 Methodology/Research Approach
    • 14.1.2 Data Source
  • 14.2 Author Details
  • 14.3 Disclaimer